Recombinant CD22 (Pinatuzumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-CD22 (Pinatuzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect CD22 (Pinatuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7488016
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant CD22 (Pinatuzumab Biosimilar) antibody (ABIN7488016)
Target
CD22 (Pinatuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This CD22 (Pinatuzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Pinatuzumab Biosimilar - Anti-CD22 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
anti-CD22 (Pinatuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD22 (Pinatuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- ACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000
Target
-
You are here:
